ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 165 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $4,539,000 | -11.5% | 364,838 | -2.6% | 0.01% | -18.2% |
Q3 2016 | $5,127,000 | +87.0% | 374,538 | +0.9% | 0.01% | +83.3% |
Q2 2016 | $2,742,000 | +20.6% | 371,038 | +4.3% | 0.01% | +20.0% |
Q1 2016 | $2,273,000 | +17.2% | 355,719 | +14.6% | 0.01% | 0.0% |
Q4 2015 | $1,939,000 | +8.7% | 310,276 | +1.6% | 0.01% | 0.0% |
Q3 2015 | $1,783,000 | -29.5% | 305,276 | -0.2% | 0.01% | -16.7% |
Q2 2015 | $2,529,000 | +1.6% | 305,776 | +1.3% | 0.01% | 0.0% |
Q1 2015 | $2,488,000 | +18.4% | 301,914 | -1.3% | 0.01% | +20.0% |
Q4 2014 | $2,102,000 | +27.8% | 305,914 | +0.4% | 0.01% | +25.0% |
Q3 2014 | $1,645,000 | -14.2% | 304,613 | +1.2% | 0.00% | -20.0% |
Q2 2014 | $1,917,000 | -29.2% | 300,985 | -10.3% | 0.01% | -28.6% |
Q1 2014 | $2,706,000 | +18.7% | 335,685 | +0.4% | 0.01% | +16.7% |
Q4 2013 | $2,280,000 | -62.7% | 334,285 | +0.7% | 0.01% | -66.7% |
Q3 2013 | $6,110,000 | +8.5% | 332,085 | +3.2% | 0.02% | 0.0% |
Q2 2013 | $5,629,000 | -1.6% | 321,838 | +1.8% | 0.02% | -5.3% |
Q1 2013 | $5,721,000 | – | 316,247 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $80,313,000 | 15.61% |
Opaleye Management Inc. | 1,310,000 | $8,188,000 | 3.42% |
Camber Capital Management LP | 5,405,235 | $33,783,000 | 2.18% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 471,516 | $2,947,000 | 1.22% |
HighVista Strategies LLC | 807,100 | $5,044,000 | 0.94% |
JS Capital Management LLC | 630,000 | $3,938,000 | 0.94% |
1492 Capital Management LLC | 202,500 | $1,266,000 | 0.92% |
Palo Alto Investors LP | 2,257,217 | $14,108,000 | 0.78% |
Geduld E E | 185,100 | $1,157,000 | 0.72% |
Elk Creek Partners, LLC | 1,592,527 | $9,953,000 | 0.71% |